These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35589407)
1. First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using Loft M; Christensen C; Clausen MM; Carlsen EA; Hansen CP; Kroman N; Langer SW; Høgdall C; Madsen J; Gillings N; Nielsen CH; Klausen TL; Holm S; Loft A; Berthelsen AK; Kjaer A J Nucl Med; 2022 Dec; 63(12):1871-1879. PubMed ID: 35589407 [TBL] [Abstract][Full Text] [Related]
2. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146 [TBL] [Abstract][Full Text] [Related]
3. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699 [TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of (18)F-labeled active site inhibited factor VII (ASIS). Erlandsson M; Nielsen CH; Jeppesen TE; Kristensen JB; Petersen LC; Madsen J; Kjaer A J Labelled Comp Radiopharm; 2015 May; 58(5):196-201. PubMed ID: 25820758 [TBL] [Abstract][Full Text] [Related]
6. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates. Tian M; Ogawa K; Wendt R; Mukhopadhyay U; Balatoni J; Fukumitsu N; Uthamanthil R; Borne A; Brammer D; Jackson J; Mawlawi O; Yang B; Alauddin MM; Gelovani JG J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803 [TBL] [Abstract][Full Text] [Related]
7. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET. Krebs S; Veach DR; Carter LM; Grkovski M; Fornier M; Mauro MJ; Voss MH; Danila DC; Burnazi E; Null M; Staton K; Pressl C; Beattie BJ; Zanzonico P; Weber WA; Lyashchenko SK; Lewis JS; Larson SM; Dunphy MPS J Nucl Med; 2020 Nov; 61(11):1580-1587. PubMed ID: 32169913 [TBL] [Abstract][Full Text] [Related]
9. Biodistribution, Tumor Detection, and Radiation Dosimetry of Young CR; Adler S; Eary JF; Lindenberg ML; Jacobs PM; Collins J; Kummar S; Kurdziel KA; Choyke PL; Mena E J Nucl Med; 2019 Apr; 60(4):492-496. PubMed ID: 30389817 [TBL] [Abstract][Full Text] [Related]
10. Radiation Dosimetry and Biodistribution of Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685 [TBL] [Abstract][Full Text] [Related]
11. Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[ Long Y; Yi C; Wu R; Zhang Y; Zhang B; Shi X; Zhang X; Zha Z Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3072-3083. PubMed ID: 37191679 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin-Targeted PET Probe, Ma X; Wang S; Wang S; Liu D; Zhao X; Chen H; Kang F; Yang W; Wang J; Cheng Z J Nucl Med; 2019 Jan; 60(1):16-22. PubMed ID: 29853651 [No Abstract] [Full Text] [Related]
13. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans. Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613 [TBL] [Abstract][Full Text] [Related]
15. Preclinical Safety Evaluation and Human Dosimetry of [ Koole M; Lohith TG; Valentine JL; Bennacef I; Declercq R; Reynders T; Riffel K; Celen S; Serdons K; Bormans G; Ferry-Martin S; Laroque P; Walji A; Hostetler ED; Briscoe RJ; de Hoon J; Sur C; Van Laere K; Struyk A Mol Imaging Biol; 2020 Feb; 22(1):173-180. PubMed ID: 31111397 [TBL] [Abstract][Full Text] [Related]
16. A microdose clinical trial to evaluate [ Lee I; Lim I; Byun BH; Kim BI; Choi CW; Woo SK; Lee KC; Kang JH; Kil HS; Park C; Chi DY; Park J; Song K; Lim SM Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):95-102. PubMed ID: 32458006 [TBL] [Abstract][Full Text] [Related]
17. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers. Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934 [TBL] [Abstract][Full Text] [Related]
18. FAPI-74 PET/CT Using Either Giesel FL; Adeberg S; Syed M; Lindner T; Jiménez-Franco LD; Mavriopoulou E; Staudinger F; Tonndorf-Martini E; Regnery S; Rieken S; El Shafie R; Röhrich M; Flechsig P; Kluge A; Altmann A; Debus J; Haberkorn U; Kratochwil C J Nucl Med; 2021 Feb; 62(2):201-207. PubMed ID: 32591493 [No Abstract] [Full Text] [Related]
19. First Evaluation of PET-Based Human Biodistribution and Dosimetry of Savi A; Incerti E; Fallanca F; Bettinardi V; Rossetti F; Monterisi C; Compierchio A; Negri G; Zannini P; Gianolli L; Picchio M J Nucl Med; 2017 Aug; 58(8):1224-1229. PubMed ID: 28209906 [No Abstract] [Full Text] [Related]
20. Biodistribution, pharmacokinetics, dosimetry of [ Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]